Deva Holding AS (DEVA.E.IS) Stock Price

Deva Holding AS Price

BIST·CLOSED
72.65
​
Market closed

Over the last 19 years Deva Holding AS grew revenue by 27.8% annually, reaching 19.25 B TRY. Earnings per share have grown at 0.0% per year over the last 17 years. For Deva Holding AS, the net margin of -4.2% is down versus 50.2% a few years ago. At today's price the dividend yield works out to roughly 0.34%. The payout ratio is around 55% of earnings. The dividend has grown at 29.1% per year over the past 2 years.

Deva Holding AS stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Deva Holding AS business model & stock analysis

Deva Holding AS engages in the production and marketing of human pharmaceuticals and raw materials. The firm has four production facilities in Turkey. Its production facilities include the Tokapi, Cerezkoy I, Cerezkoy II and Kartepe production plants. The Company’s product portfolio comprises 73 drugs, which are available on the market in 177 various forms. The company offers products, such as Azitro, Alemax, Cefax, Inhibace, Imatis, Hydrea, Kardozin, Kristapen, Magcar, Magnesie Calcinee, Nostil, Oceral, Remidon, Prolixin and Quet, among others. The firm has two subsidiaries, namely Vetaa Veteriner ve Tarim Ilaclari A.S. and Deva Holding NZ Ltd.

Frequently asked questions about Deva Holding AS

Converted at the current exchange rate, the Deva Holding AS share trades at 1.30 EUR (72.65 TRY).

The revenue cannot currently be calculated for Deva Holding AS.

The profit cannot currently be calculated for Deva Holding AS.

The P/E ratio cannot be calculated for Deva Holding AS at the moment.

The P/S cannot be calculated for Deva Holding AS currently.

The Eulerpool Quality Score for Deva Holding AS is 3/10.

The ISIN of Deva Holding AS is TRADEVAW91E2. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Deva Holding AS is DEVA.E.IS. The ticker symbol is used to trade Deva Holding AS shares on the stock exchange.

Fair ValueTerminal
72.65 TRY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
6.57 M TRY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website deva.com.tr
Country
Türkiye
Currency
TRY
Initial public offering
Mar 24, 1986
ISIN
TRADEVAW91E2
Cusip
M2789A106
Market capitalization
14.41 B TRYLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
1,366.84
P/B Ratio
0.55
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-3.01 %
Dividend
Dividend yield
0.00 %
Payout Ratio
19.28 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
0.00 %
Last updated Oct 23, 2026, 6:31 PM

Deva Holding AS Peer Group

Deva Holding AS Ticker

IST · DEVA.IS

Deva Holding AS FIGI

DEVA:TI · BBG000BVBN69DEVA:TF · BBG0015R2MH3DEVA:TS · BBG0015R2MJ1DEVAY:PO · BBG00JXJJT51DEVAY:L3 · BBG00JXJKW25DEVAY:B3 · BBG00JXJLC46DEVAY:L1 · BBG00Y7BS4L1DEVATRY:XS · BBG017T99MK2DEVATRY:X2 · BBG017T99ML1DEVATRY:XH · BBG017T99MN9DEVATRY:XF · BBG017T99MQ6DEVATRY:XE · BBG017T99MT3